CVRx (CVRX) announced the enrollment of the first patient in the BENEFIT-HF trial at North Central Heart – a division of the Avera Heart Hospital, in Sioux Falls. The BENEFIT-HF trial is expected to continue through 2032.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVRX: